Outcomes after radiation therapy for T2N0/stage II glottic squamous cell carcinoma

We report outcomes for patients with T2N0M0 glottic squamous cell carcinoma (SCC) treated with radiation therapy (RT).

[1]  A. Garden,et al.  Outcomes of carotid‐sparing IMRT for T1 glottic cancer: Comparison with conventional radiation , 2020, The Laryngoscope.

[2]  A. Kishan,et al.  Addition of Chemotherapy Is Associated With Decreased Survival in Early-Stage (T1-2N0M0) Glottic Squamous Cell Carcinoma Treated With Definitive Radiotherapy. , 2019, JCO precision oncology.

[3]  B. Chan,et al.  Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiation Therapy Intensification. , 2018, International journal of radiation oncology, biology, physics.

[4]  Steven J Frank,et al.  Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy. , 2017, International journal of radiation oncology, biology, physics.

[5]  E. Erkul,et al.  The presence and prognostic significance of human papillomavirus in squamous cell carcinoma of the larynx , 2017, European Archives of Oto-Rhino-Laryngology.

[6]  D. Lora Pablos,et al.  HPV in Larynx Squamous Cell Carcinoma: New Serotypes and Survival Study within 10-Year Follow-up. , 2017, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[7]  C. B. Carcavilla,et al.  HPV in Larynx Squamous Cell Carcinoma: New Serotypes and Survival Study within 10-Year Follow-up. , 2017 .

[8]  B. Burkey,et al.  Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone , 2016, Head & neck.

[9]  A. Amini,et al.  Improved Survival With 3DCRT Over IMRT in Early-Stage Larynx Cancer: A National Cancer Data Base Analysis , 2016 .

[10]  S. Woo,et al.  Carotid sparing intensity modulated radiotherapy on early glottic cancer: preliminary study , 2016, Radiation oncology journal.

[11]  J. Overgaard,et al.  The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  E. Ermis,et al.  Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions , 2015, Radiation Oncology.

[13]  C. Matthiesen,et al.  Dosimetric and radiobiologic comparison of 3D conformal, IMRT, VMAT and proton therapy for the treatment of early‐stage glottic cancer , 2015, Journal of medical imaging and radiation oncology.

[14]  H. Joensuu,et al.  Voice quality after treatment of early vocal cord cancer: a randomized trial comparing laser surgery with radiation therapy. , 2014, International journal of radiation oncology, biology, physics.

[15]  Christopher U. Jones,et al.  Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512). , 2014, International journal of radiation oncology, biology, physics.

[16]  E. Chung,et al.  A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  R. Weber,et al.  Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  H. Nam,et al.  Definitive Radiation Therapy for Early Glottic Cancer: Experience of Two Fractionation Schedules , 2012, Clinical and experimental otorhinolaryngology.

[19]  M. Ikeda,et al.  Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone , 2012, Acta oto-laryngologica.

[20]  A. Rinaldo,et al.  Human papillomavirus infections in laryngeal cancer , 2011, Head & neck.

[21]  W. Mendenhall,et al.  T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[22]  J. Mechalakos,et al.  An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer , 2010, Radiation oncology.

[23]  W. Mendenhall,et al.  Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord. , 2010, International journal of radiation oncology, biology, physics.

[24]  S. Naganawa,et al.  Radiotherapy with or without chemotherapy for patients with T1-T2 glottic carcinoma: retrospective analysis , 2010, Head & neck oncology.

[25]  J F Fowler,et al.  21 years of biologically effective dose. , 2010, The British journal of radiology.

[26]  A. Garden,et al.  Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer. , 2010, International journal of radiation oncology, biology, physics.

[27]  R. Hart,et al.  Radiotherapy for T1 and T2 laryngeal cancer: the Dalhousie University experience. , 2009, Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale.

[28]  Edward D McCoul,et al.  Meta-analysis of impaired vocal cord mobility as a prognostic factor in T2 glottic carcinoma. , 2009, Archives of otolaryngology--head & neck surgery.

[29]  T. Taguchi,et al.  Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation. , 2009, Anticancer research.

[30]  A. Garden,et al.  Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  K. Okami,et al.  Concurrent chemoradiotherapy with docetaxel for T2 laryngeal carcinoma. , 2008, The Tokai journal of experimental and clinical medicine.

[32]  N. Agrawal,et al.  Management of early-stage laryngeal cancer. , 2008, Otolaryngologic clinics of North America.

[33]  S. Feigenberg,et al.  Intensity-modulated radiotherapy for early larynx cancer: is there a role? , 2007, International journal of radiation oncology, biology, physics.

[34]  P. Simcock,et al.  TN/TN glottic carcinoma: a comparison of two fractionation schedules. , 2006, Australasian radiology.

[35]  T. Taguchi,et al.  Concurrent chemoradiotherapy with carboplatin and uracil–ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx , 2006, The Journal of Laryngology & Otology.

[36]  H. Yamazaki,et al.  Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. , 2006, International journal of radiation oncology, biology, physics.

[37]  Y. Itoh,et al.  Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer , 2006, Radiation Medicine.

[38]  W. Mendenhall,et al.  Management of T1–T2 glottic carcinomas , 2004, Cancer.

[39]  A. Garden,et al.  Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? , 2003, International journal of radiation oncology, biology, physics.

[40]  C. Grau,et al.  Glottic carcinoma--patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  W. Mendenhall,et al.  T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  R. Bristow,et al.  T1/T2 GLOTTIC CANCER MANAGED BY EXTERNAL BEAM RADIOTHERAPY: THE INFLUENCE OF PRETREATMENT HEMOGLOBIN ON LOCAL CONTROL , 1998 .

[43]  J. Quivey,et al.  Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. , 1997, International journal of radiation oncology, biology, physics.

[44]  J. Overgaard,et al.  Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. , 1990, International journal of radiation oncology, biology, physics.

[45]  A. Lauritzen,et al.  Stage I glottic carcinoma: an analysis of tumour recurrence after primary radiotherapy. , 1990, Clinical oncology (Royal College of Radiologists (Great Britain)).

[46]  F. Eschwège,et al.  Radiation therapy in the treatment of early glottic carcinoma: the experience of Villejuif. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[47]  G. Fletcher,et al.  T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. , 1988, International journal of radiation oncology, biology, physics.

[48]  B. Cummings,et al.  T2 glottic cancer: an analysis of dose-time-volume factors. , 1981, International journal of radiation oncology, biology, physics.

[49]  B. Cummings,et al.  Radiotherapy of early glottic cancer , 1980, The Laryngoscope.

[50]  A. Harwood,et al.  Radiotherapy of early glottic cancer--II. , 1979, International journal of radiation oncology, biology, physics.

[51]  G. Fletcher,et al.  Analysis of failures in early vocal-cord cancer. , 1972, Radiology.